However, there were no significant differences in the percentages of YFP+ leukemia cells in the peripheral blood, the sizes of the leukemic spleens and livers, the YFP+Mac-1+c-Kit+ LIC frequencies and the survival between the recipients receiving WT and ChREBP-null cells (Supplementary Figure 1A–1B and 1G–1K), We noticed that there was a slightly increased frequency of ChREBP-null YFP+Mac-1+Gr-1− leukemia cells in the peripheral blood, although the increase was not significant (Supplementary Figure 1C–1D). This evidence concerns the gene MLXIPL and leukemia.